
Vijoy 37.5mg Capsule XR
Marketer
Ikon Pharmachem Pvt Ltd
Salt Composition
Venlafaxine (37.5mg)
Overview Vijoy 37.5mg Capsule XR
Deprexis XR 37.5mg capsules treat anxiety and depressive disorders. This medication modifies brain chemistry, addressing symptoms like restlessness, poor concentration, tiredness, excessive perspiration, rapid heartbeat, racing thoughts, and irritability. Take Deprexis XR 37.5mg with food, at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon recall. Complete the prescribed course, even if feeling improved; do not discontinue abruptly, as symptom worsening may occur. Common side effects include nausea, vomiting, sleep disturbances, reduced appetite, heightened anxiety, constipation, increased sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or mentally demanding tasks until effects are known. Most side effects are transient and self-limiting. Consult your physician if side effects persist or are troublesome. Prior to commencing Deprexis XR 37.5mg, disclose any kidney, heart, or liver conditions, or history of seizures to your doctor. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation immediately.
Primary Ingredients of Vijoy 37.5mg Capsule XR
No text provided. Please provide the text you wish me to rephrase.
Uses of Vijoy 37.5mg Capsule XR
Mood disorders encompassing depressive and anxious symptoms
Major Benefits of Vijoy 37.5mg Capsule XR:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Vijoy 37.5mg Extended-Release Capsules should be administered with a meal.
Common Side effects of Vijoy 37.5mg Capsule XR:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Vijoy 37.5mg Capsule XR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire capsule; avoid chewing, crushing, or breaking it. Vijoy 37.5mg Extended-Release Capsules should be taken with a meal.
How Vijoy 37.5mg Capsule XR works:
Extended-release Vijoy 37.5mg capsules elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for preserving mental equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Vijoy 37.5mg Capsule XR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vijoy 37.5mg capsules may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vijoy 37.5mg capsules are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant. Close observation of infants for drowsiness and appropriate weight increase is recommended.
DrivingUNSAFE
Driving ability may be impaired by Vijoy 37.5mg Capsule XR, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.
KidneyCAUTION
Extended-release Vijoy 37.5mg capsules require careful administration for individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Vijoy 37.5mg extended-release capsules. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vijoy 37.5mg Capsule XR :
Should you forget a dose of Vijoy 37.5mg Capsule XR, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vijoy 37.5mg Capsule XR
| Label | Value |
|---|---|
| Chemical Classification | Anisole-based compound |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) |
| Behavioral Class | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
